Your browser doesn't support javascript.
loading
Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists.
Neumiller, Joshua J; Shubrook, Jay H; Manley, Tom; Alicic, Radica Z; Tuttle, Katherine R.
Afiliação
  • Neumiller JJ; College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.
  • Shubrook JH; Primary Care Department, Touro University, Vallejo, CA, USA.
  • Manley T; National Kidney Foundation, New York, NY, USA.
  • Alicic RZ; Providence Medical Research Center, Providence Health Care, Spokane, WA, and Division of Medicine, University of Washington, Spokane and Seattle, WA, USA.
  • Tuttle KR; Providence Medical Research Center, Providence Health Care, Spokane, WA, and Division of Nephrology, Kidney Research Institute, University of Washington, Spokane and Seattle, WA, USA.
Am J Health Syst Pharm ; 79(1): e65-e70, 2022 01 01.
Article em En | MEDLINE | ID: mdl-34185826
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2022 Tipo de documento: Article